Dalteparin
4198731
224590207
2008-07-09T15:34:31Z
Pirsig
7448629
'''Dalteparin''' is a [[low molecular weight heparin]]. It is marketed as Fragmin by [http://www.eisai.com Eisai]. Like other low molecular weight heparins, dalteparin is used for prophylaxis or treatment of [[deep vein thrombosis]] and [[pulmonary embolism]].
The CLOT study, published in 2003, showed that in patients with malignancy and acute venous thromboembolism, dalteparin was more effective than [[coumadin]] in reducing the risk of recurrent embolic events.<ref>{{cite journal | author=Lee AY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M, Rickles FR, Julian JA, Haley S, Kovacs MJ, Gent M | title=Low-molecular-weight heparin versus a Coumadin for the prevention of recurrent venous thromboembolism in patients with cancer | journal=N Engl J Med | year=2003 | pages=146–53 | volume=349 | issue=2 | pmid=12853587 | doi=10.1056/NEJMoa025313}}
</ref>
==References==
<!--See http://en.wikipedia.org/wiki/Wikipedia:Footnotes for an explanation of how to generate footnotes or references using the <ref(erences/)> tags-->
<references/>
[[Category:Anticoagulants]]
{{treatment-stub}}
{{Antithrombotics}}
[[nn:Dalteparin]]
[[pl:Dalteparyna]]